Medartis Holding AG header image

Medartis Holding AG

MED

Equity

ISIN CH0386200239 / Valor 38620023

SIX Swiss Exchange (2026-05-04)
CHF 76.45+5.20%

Medartis Holding AG
UMushroom community rating:

star star star star star
5.00 1 votes No rating yet
NegativeNeutralPositive

About company

Medartis Holding AG is a Swiss medical‑device company that develops, manufactures and sells internal fixation implants, instruments and surgical systems for orthopaedic and trauma applications, with particular emphasis on fixation of small and medium bones such as those of the hand, wrist, foot/ankle and cranio‑maxillofacial areas. Its product range includes titanium and stainless‑steel plates, screws, locking systems and complementary surgical instruments, which it supplies to hospitals and surgeons through a network of subsidiaries and distributors across multiple regions; the business model is driven by product sales, aftermarket instrumentation and incremental R&D and regulatory work to broaden its clinical portfolio. As a publicly listed specialist in the orthopaedic-trauma segment, Medartis competes on product engineering, clinical support and targeted market coverage rather than on broad hospital consumable lines.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

0.13%1Y
3.78%3Y
4.63%5Y

Performance

37.1%1Y
42.5%3Y
42.7%5Y

Volatility

Market cap

1225 M

Market cap (USD)

Daily traded volume (Shares)

17,472

Daily traded volume (Shares)

1 day high/low

59.6 / 51.2

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

5.00

1 votes
Performance:
starstarstarstarstar
5.00
Innovation:
starstarstarstarstar
4.00
Society:
starstarstarstarstar
3.00
Nature:
starstarstarstarstar
3.00
Peter Jürg Burkard
Switzerland, 26 Mar 2025
star star star star star
Scheint gut zu laufen.

EQUITIES OF THE SAME SECTOR

Embla Medical hf
Embla Medical hf Embla Medical hf Valor: 1060135
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%DKK 26.75
H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.13%DKK 35.00
Teladoc Health Inc
Teladoc Health Inc Teladoc Health Inc Valor: 28438140
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.60%USD 6.46
Bristol-Myers Squibb Co
Bristol-Myers Squibb Co Bristol-Myers Squibb Co Valor: 914188
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.91%USD 58.22
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.11%CHF 7.15
Demant A/S
Demant A/S Demant A/S Valor: 32651962
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.47%DKK 209.00
Paul Hartmann AG
Paul Hartmann AG Paul Hartmann AG Valor: 1547181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.97%EUR 204.00
Ensign Group Inc
Ensign Group Inc Ensign Group Inc Valor: 3109721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.59%USD 183.72
Estee Lauder Companies Inc
Estee Lauder Companies Inc Estee Lauder Companies Inc Valor: 99350
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 79.30
Alk-Abello A/S
Alk-Abello A/S Alk-Abello A/S Valor: 117689788
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.51%DKK 242.00